Revvity, Inc. (RVTY) stock

RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29

Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Aug 11, 2026Score 11/3049% above fair value

$157.00−8.78 (-5.30%)

Close on Oct 30, 2026Market cap $17.52BP/E 74.8Yield 0.18%

Earnings

Revvity's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Oct 26, 2026

Q3 FY2026 · estimated, before the open

Revenue, Q2 FY2026

$730.00M

+1.4% on a year earlier

Adjusted earnings per share from continuing operations, Q2 FY2026

$1.41

$1.18 a year earlier

Latest guidance

Raised

Aug 4, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Revvity's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 28, 2026	Oct 26, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jul 5, 2026	Aug 4, 2026before the open	$730.00M	+1.4%	$0.48	$1.41	Release
Q1 FY2026ended Apr 5, 2026	May 5, 2026before the open	$711.00M	+6.9%	$0.37	$1.06	Release
Q4 FY2025ended Dec 28, 2025	Feb 2, 2026before the open	$772.00M	+5.9%	$0.87	$1.70	Release
Q3 FY2025ended Sep 28, 2025	Oct 27, 2025before the open	$699.00M	+2.2%	$0.40	$1.18	Release
Q2 FY2025ended Jun 29, 2025	Jul 28, 2025before the open	$720.00M	+4.0%	$0.46	$1.18	Release
Q1 FY2025ended Mar 30, 2025	Apr 28, 2025before the open	$665.00M	+2.3%	$0.35	$1.01	Release
Q4 FY2024ended Dec 29, 2024	Jan 31, 2025before the open	$729.00M	+4.7%	$0.78	$1.42	Release
Q3 FY2024ended Sep 29, 2024	Nov 4, 2024before the open	$684.00M	+1.9%	$0.77	$1.28	Release
Q2 FY2024ended Jun 30, 2024	Jul 29, 2024before the open	$692.00M	-2.4%	$0.45	$1.22	Release
Q1 FY2024ended Mar 31, 2024	Apr 29, 2024before the open	$650.00M	-3.7%	$0.21	$0.98	Release
Q4 FY2023ended Dec 31, 2023	Feb 1, 2024before the open	$696.00M	-6.1%	$0.64	$1.25	Release
Q3 FY2023ended Oct 1, 2023	Oct 30, 2023before the open	$671.00M	-5.8%	$0.08	$1.18	Release
Q2 FY2023ended Jul 2, 2023	Aug 1, 2023before the open	$709.00M	-42.4%	$0.28	$1.21	Release
Q1 FY2023ended Apr 2, 2023	May 11, 2023before the open	$675.00M	-46.4%	$4.50	$1.01	Release
Q4 FY2022ended Jan 1, 2023	Feb 14, 2023before the open	$741.00M	-45.5%	$0.85	$1.70	Release
Q3 FY2022ended Oct 2, 2022	Nov 8, 2022before the open	$712.00M	-39.1%	$0.55	$1.51	Release
Q2 FY2022ended Jul 3, 2022	Aug 1, 2022before the open	$1.23B	–	$1.42	$2.32	Release
Q1 FY2022ended Apr 3, 2022	May 3, 2022after the close	$1.26B	–	$1.40	$2.41	Release
Q4 FY2021ended Jan 2, 2022	Feb 1, 2022after the close	$1.36B	–	$1.41	$2.56	Release
Q3 FY2021ended Oct 3, 2021	Nov 2, 2021after the close	$1.17B	–	$1.11	$2.31	Release
Q2 FY2021ended Jul 4, 2021	Jul 26, 2021before the open	–	–	–	–	Release
Q1 FY2021ended Apr 4, 2021	Apr 13, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Jan 3, 2021	Feb 2, 2021after the close	–	–	–	–	Filing
Q3 FY2020ended Oct 4, 2020	Oct 13, 2020before the open	–	–	–	–	Filing
Q2 FY2020ended Jul 5, 2020	Jul 13, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Revvity's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
organic revenue growthnon-GAAP	FY2026	+2% – +3%	–	New	Feb 2, 2026
pro forma organic revenue growthnon-GAAP	FY2026	+4% – +5%	+3% – +4%	Raised	Aug 4, 2026
total revenue	FY2026	$2.83B – $2.86B	$2.81B – $2.84B	Raised	Aug 4, 2026
total revenueGAAP	FY2026	$2.96B – $2.99B	–	New	Feb 2, 2026
adjusted earnings per sharenon-GAAP	FY2026	$5.35 – $5.45	–	New	Feb 2, 2026
pro forma adjusted earnings per sharenon-GAAP	FY2026	$5.30 – $5.40	$5.20 – $5.30	Raised	Aug 4, 2026

Guidance vs results

The last range Revvity gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	adjusted EPS	$4.90 – $5.00	$5.07Σ4Q	Above range
FY2025	Revenue	$2.86B	$2.86BΣ4Q	Within range
FY2025	Revenue growth	+4%	+3.67%Σ4Q	Below range
Q4 FY2025	Revenue	$772.00M	$772.00M	Within range
Q4 FY2025	Revenue growth	+6%	+5.9%	Below range
Q4 FY2024	Revenue	$730.00M	$729.00M	Below range
Q4 FY2024	Revenue growth	+5%	+4.74%	Below range
Q4 FY2022	pro forma adjusted earnings per share	$1.65 – $1.67	$1.70	Above range
Q4 FY2022	Revenue	$730.00M	$741.00M	Above range
Q3 FY2022	adjusted earnings per share	$1.40 – $1.45	$1.51	Above range
Q3 FY2022	Revenue	$1.02B – $1.03B	$712.00M	Below range
Q2 FY2022	Adjusted earnings per share	$2.00 – $2.05	$2.32	Above range
Q2 FY2022	Revenue	$1.20B – $1.22B	$1.23B	Above range
Q1 FY2022	adjusted earnings per share	$2.05 – $2.10	$2.41	Above range
Q1 FY2022	Revenue	$1.17B – $1.19B	$1.26B	Above range
Q4 FY2021	adjusted earnings per share	$2.05	$2.56	Above range
Q4 FY2021	Revenue	$1.20B	$1.36B	Above range

Guidance history

Every forecast Revvity put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 4, 2026	pro forma adjusted earnings per share	FY2026	$5.30 – $5.40	Raised
Aug 4, 2026	total revenue	FY2026	$2.83B – $2.86B	Raised
Aug 4, 2026	pro forma organic revenue growth	FY2026	+4% – +5%	Raised
May 5, 2026	pro forma adjusted earnings per share	FY2026	$5.20 – $5.30	New
May 5, 2026	total revenue	FY2026	$2.81B – $2.84B	New
May 5, 2026	pro forma organic revenue growth	FY2026	+3% – +4%	New
Feb 2, 2026	adjusted earnings per share	FY2026	$5.35 – $5.45	New
Feb 2, 2026	total revenue	FY2026	$2.96B – $2.99B	New
Feb 2, 2026	organic revenue growth	FY2026	+2% – +3%	New
Jan 13, 2026	revenue	Q4 FY2025	$772.00M	New
Jan 13, 2026	organic revenue growth	Q4 FY2025	+4%	New
Jan 13, 2026	Reported revenue growth	Q4 FY2025	+6%	New
Jan 13, 2026	revenue	FY2025	$2.86B	Narrowed
Jan 13, 2026	organic revenue growth	FY2025	+3%	Narrowed
Jan 13, 2026	Reported revenue growth	FY2025	+4%	New
Oct 27, 2025	adjusted EPS	FY2025	$4.90 – $5.00	Raised
Oct 27, 2025	organic growth	FY2025	+2% – +4%	Reaffirmed
Oct 27, 2025	full year revenue	FY2025	$2.83B – $2.88B	Lowered
Oct 27, 2025	Revenue growth from continuing operations	FY2025	+3% – +5%	New
Jul 28, 2025	adjusted EPS	FY2025	$4.85 – $4.95	New
Jul 28, 2025	revenue	FY2025	$2.84B – $2.88B	New
Jul 28, 2025	organic growth	FY2025	+2% – +4%	New
Apr 28, 2025	adjusted EPS guidance	FY2025	$4.90 – $5.00	Reaffirmed
Apr 28, 2025	organic growth guidance	FY2025	+3% – +5%	New
Apr 28, 2025	revenue guidance	FY2025	$2.83B – $2.87B	Raised
Jan 31, 2025	adjusted earnings per share	FY2025	$4.90 – $5.00	New
Jan 31, 2025	total revenue	FY2025	$2.80B – $2.85B	New
Jan 13, 2025	revenue	Q4 FY2024	$730.00M	New
Jan 13, 2025	organic revenue growth	Q4 FY2024	+6%	New
Jan 13, 2025	Reported revenue growth	Q4 FY2024	+5%	New
Nov 4, 2024	adjusted EPS	FY2024	$4.83 – $4.87	Raised
Nov 4, 2024	revenue	FY2024	$2.75B – $2.77B	New
Nov 4, 2024	organic growth	FY2024	0% – +1%	Lowered
Jul 29, 2024	adjusted EPS	FY2024	$4.70 – $4.80	Raised
Jul 29, 2024	revenue	FY2024	$2.77B – $2.79B	Lowered
Apr 29, 2024	adjusted EPS	FY2024	$4.55 – $4.75	Reaffirmed
Apr 29, 2024	organic growth	FY2024	+1% – +3%	New
Apr 29, 2024	total revenue	FY2024	$2.76B – $2.82B	New
Feb 1, 2024	adjusted earnings per share	FY2024	$4.55 – $4.75	New
Feb 1, 2024	total revenue	FY2024	$2.79B – $2.85B	New
Oct 30, 2023	adjusted earnings per share	FY2023	$4.53 – $4.57	Lowered
Oct 30, 2023	total revenue	FY2023	$2.72B – $2.74B	Lowered
Aug 1, 2023	adjusted earnings per share	FY2023	$4.70 – $4.90	Lowered
Aug 1, 2023	total revenue	FY2023	$2.80B – $2.85B	Lowered
May 11, 2023	adjusted earnings per share	FY2023	$4.85 – $5.05	Lowered
May 11, 2023	total revenue	FY2023	$2.90B – $2.94B	Lowered
Feb 14, 2023	adjusted earnings per share	FY2023	$5.05	New
Feb 14, 2023	total revenue from continuing operations	FY2023	$2.94B	New
Nov 8, 2022	pro forma adjusted earnings per share	FY2022	$7.89 – $7.91	Raised
Nov 8, 2022	pro forma adjusted earnings per share	Q4 FY2022	$1.65 – $1.67	New
Nov 8, 2022	total revenue from continuing operations	Q4 FY2022	$730.00M	New
Nov 8, 2022	total revenue from continuing operations	FY2022	$3.30B	New
Nov 8, 2022	Pro forma total revenue	FY2022	$4.59B – $4.60B	Lowered
Nov 8, 2022	Pro forma total revenue	Q4 FY2022	$1.06B – $1.07B	New
Aug 1, 2022	adjusted earnings per share	FY2022	$7.80 – $7.90	Raised
Aug 1, 2022	adjusted earnings per share	Q3 FY2022	$1.40 – $1.45	New
Aug 1, 2022	revenue	Q3 FY2022	$1.02B – $1.03B	New
Aug 1, 2022	revenue	FY2022	$4.60B – $4.64B	Raised
May 3, 2022	Adjusted earnings per share	Q2 FY2022	$2.00 – $2.05	New
May 3, 2022	adjusted earnings per share	FY2022	$7.15 – $7.45	Raised
May 3, 2022	revenue	Q2 FY2022	$1.20B – $1.22B	New
May 3, 2022	revenue	FY2022	$4.56B – $4.63B	Raised
Feb 1, 2022	adjusted earnings per share	Q1 FY2022	$2.05 – $2.10	New
Feb 1, 2022	adjusted earnings per share	FY2022	$6.80 – $7.00	New
Feb 1, 2022	revenue	Q1 FY2022	$1.17B – $1.19B	New
Feb 1, 2022	revenue	FY2022	$4.42B – $4.50B	New
Nov 2, 2021	adjusted earnings per share	Q4 FY2021	$2.05	New
Nov 2, 2021	adjusted earnings per share	FY2021	$10.81	New
Nov 2, 2021	adjusted revenue	Q4 FY2021	$1.20B	New
Nov 2, 2021	adjusted revenue	FY2021	$4.90B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.